Loading
IARC estimates 27,260 new cancer cases and 17,662 cancer deaths in Ghana in 2024; the commonest new cancers are breast, cervix uteri and liver and intrahepatic bile ducts. This page is assembled automatically from OnCo's data: 2 trials with a site there, 3 institutions, 1 company and 2 people, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 5,487 | 40.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 3,740 | 30.4 | Cervical cancer |
| Liver and intrahepatic bile ducts | 2,975 | 11.7 | Hepatocellular carcinoma |
| Prostate | 2,817 | 32.5 | Prostate cancer |
| Ovary | 1,268 | 9.5 | Ovarian cancer |
| Non-Hodgkin lymphoma | 1,115 | 3.8 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Stomach | 1,061 | 4.9 | Gastric & gastro-oesophageal junction cancer |
| Colorectum | 1,044 | 4.6 | Colorectal cancer |
| Trachea, bronchus and lung | 660 | 3.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Bladder | 629 | 2.9 | Bladder & urothelial cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 2,695 | 20.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Liver and intrahepatic bile ducts | 2,640 | 10.6 | Hepatocellular carcinoma |
| Cervix uteri | 2,324 | 19.2 | Cervical cancer |
| Prostate | 1,784 | 20.4 | Prostate cancer |
| Stomach | 926 | 4.3 | Gastric & gastro-oesophageal junction cancer |
| Ovary | 856 | 6.7 | Ovarian cancer |
| Trachea, bronchus and lung | 597 | 2.9 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 593 | 2.7 | Colorectal cancer |
| Non-Hodgkin lymphoma | 545 | 2.0 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Pancreas | 505 | 2.4 | Pancreatic ductal adenocarcinoma |
| Trial | Lead sponsor | ||||
|---|---|---|---|---|---|
| Phase 2 | Not yet recruiting | The University of The West Indies | 3 | 2026-09-22 | |
| Phase 3 | Active not recruiting | Hoffmann-La Roche | 171 | 2025-12-31 |
Trial records in OnCo whose ClinicalTrials.gov entry lists at least one site in Ghana, captured 2026-10-07 to 2026-10-07. Recruiting first, then the most recently updated. The status is the study's overall status; whether a site in Ghana is open is on the registry page, under Contacts and Locations.
People whose main affiliation in OnCo is an institution or company in Ghana.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Ghana is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Ghana is ranked 41 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.